Context. The Palliative care Outcome Scale (POS) and the Support Team Assessment Schedule (STAS) are two outcome measures used in palliative care settings to assess palliative concerns, needs, and quality of care.
Introduction
Outcome measures have an increasingly important role in health care. These are measures that help to record a patient's change in health over time, as a result of health care or interventions. 1 The implementation of outcome measures is important for improving the quality of service delivery and promoting accountability. In particular, patient-reported outcome measures (PROMs or PROs) are increasingly recognized as a good way to inform the delivery of health care and promote patient-centered care, as outcomes directly reflect the difference made for the patient. 2 The Support Team Assessment Schedule (STAS) and the Palliative care (or Patient) Outcome Scale (POS) are examples of outcome measures specifically developed for palliative care. The STAS was developed in 1986 as a standardized measure to evaluate the work of palliative care support teams. Its 17 items can be rated from 0 (best) to 4 (worst) by a patient's professional caregiver. These items measure patient symptoms, anxiety and insight, family anxiety and insight, quality of communication with health care professionals and carers, and the need for practical support. Cohen kappas for STAS items were greater than 0.48 (up to 0.87), with high correlation coefficients (Spearman rho ranged 0.65e0.94).
3,4
The POS was developed in 1999 following the success of the STAS. This measure was designed for use with advanced cancer patients and evaluates similar outcomes to the STAS, but with an additional patient-reported element. The POS demonstrated good construct validity (Spearman rho ¼ 0.43e0.80), as well as test/retest reliability. 5 Internal consistency of the different versions of the measure was also good (Cronbach alpha ¼ 0.65 [patients] , 0.70 [staff]). 5 The 10 items of the POS assess physical symptoms, psychological, emotional, and spiritual needs, and the provision of information and practical support. Two versions of the original (''core'') POS are available for use in specialist and nonspecialist palliative care settings. The latter is also referred to as the ''Patient Outcome Scale'' in some studies.
6 This is recommended when POS is used in a population that will not necessarily be familiar with or introduced to the term palliative care, such as screening those with long-term conditions for palliative care needs. The POS-S is a further development of the POS that incorporates a symptom list. Extended versions of the POS-S have been developed for use with those living with multiple sclerosis (POS-S-MS), parkinson disease (POS-S-PP), and end-stage renal disease (POS-S-renal). Additional POS measures (POS-S and Integrated Palliative care Outcome Scale [IPOS] ) represent refinements of POS to capture more detail about symptoms (POS-S) or to integrate the core POS with the symptom module POS-S (IPOS). In addition, POS is being developed as a screening measure to assess needs of dementia patients residing in care homes.
One of the main challenges to the use of PROMs in palliative care is the high proportion of palliative care patients with impaired cognition or those who are otherwise too unwell to complete them. In some palliative care settings, nearly 60% of all patients were unable to complete PROMs unaided. 7 It is helpful, therefore, to use the term ''patient-centered outcome measures, '' 8 which refers to measures that encapsulate the priorities of patients themselves, but may include proxy reporting (i.e., they are completed with help from family or professionals, or directly by professionals themselves). Of note, the POS exists in patient, health professional, and carer versions, and so supports this approach.
A review was conducted in 2010 to appraise the use of the POS and STAS since their development. To build on these findings, the present review aims to appraise the use of the POS and STAS, especially in the context and nature of their use and identify strengths and weaknesses, by identifying and analyzing publications about their use since 2010.
Methods

Design
We conducted a systematic literature review to update the previous review by Bausewein et al., 7 including references up to 2014. We followed standard review methodologies as outlined by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRIS-MA) statement, which is an evidence-based minimum set of items for reporting systematic reviews.
9,10
Search Strategy
We used a predefined search strategy. Articles were identified by a comprehensive search of five electronic databases: MEDLINE, Embase, PsycINFO, British Nursing Index, and CINAHL. Databases were searched for articles published between January 1, 2010 and June 9, 2014. The following search terms were used in an advanced key word search, or an advanced abstract search where the key word search function was unavailable: ''Support Team Assessment Schedule''; ''STAS and palliative''; ''Palliative Care Outcome Scale''; ''Palliative Outcome Scale''; ''Patient Outcome Scale''; and ''POS and palliative.'' To identify any further articles, the reference lists of relevant articles were reviewed, users registered to the POS website (www.pos-pal.org) were contacted for additional publications, and a list of publications from the Department of Palliative Care, Policy and Rehabilitation, King's College London, was searched for relevant records from 2010 onward. Full details of the search strategy are presented in Appendix I (available at jpsmjournal.com).
Inclusion and Exclusion Criteria
Inclusion criteria were as follows: 1) those publications that focused on the validation of POS (and related measures, e.g., POS-S) or STAS; 2) reported psychometric testing or psychometric properties of the original measures or of translations; and 3) those publications that used the POS (and related measures, e.g., POS-S) or STAS to collect data. Exclusion criteria were as follows: 1) review articles; 2) publications before January 2010; and 3) publications already included in the previous review. PA) and screened to remove duplicates, conference abstracts, reviews, and research agendas. The abstracts of the remaining studies were assessed, with eligible studies being further subjected to full-text screening before being included in the systematic review.
Data Extraction and Analysis
Data were extracted from included studies and tabulated in a spreadsheet. Data captured included year of publication, author, study location/country, sample population, how the outcome measure was being used, study design, study aim, and results of the study. Details are in Appendix II (available at jpsmjournal. com). Articles were then categorized by their main objective and purpose of the use of the outcome measure, for example, study of symptom prevalence within a population. Details are in Appendix III (available at jpsmjournal.com). Both of these processes were carried out by one researcher (E. C.) independently, with the process repeated for 10% of studies by another independent researcher (J. W.). Raters agreed on 68% of items. Any discrepancies were discussed with the senior authors until agreement was reached.
Data Synthesis
Extracted data from the studies were tabulated by classification according to their main objective. Data were then further synthesized into tables to show countries, translations, and populations in which the measures were used. These data were reported independently and in total with the data reported in the previous review by Bausewein et al. 7 
Results
Study Selection
Overall, 178 articles were identified from the database search, and 10 additional articles were identified through contacts, scanning of reference lists, and departmental publications (Fig. 1) . After exclusion of duplicates and nonrelevant articles, 43 studies remained: 35 on one of the POS family of measures and eight on the STAS. Characteristics of the included studies may be found in Appendices II and III (available at jpsmjournal.com).
In addition, we were made aware of four ongoing studies that used or validated the POS, but these would not be ready for publication until after the publication of this review. Details of these studies can be found in Appendix IV (available at jpsmjournal.com).
Study Designs and Aims
Of the 35 POS studies included, 24 were observational 6,11e33 and 11 were experimental.
34e44
Of the observational studies, 10 were cross- Of the eight STAS studies included, seven were observational 45e51 and one was experimental. 52 Of the observational studies, two were cross-sectional 45, 46 and five were longitudinal. 47e51 The experimental study was longitudinal. 52 A total of 8728 palliative care patients contributed data to the included POS and STAS studies.
Population
Both POS and STAS measures can be applied for a variety of diagnoses. As depicted in Table 1 , these tools have both been used predominantly with cancer patients, but also with populations with HIV/AIDS. Since the previous review, STAS has only been applied to cancer patients 45e48,50e52 and those with unspecified palliative care needs. 49 In contrast, the POS has been applied not only for cancer, Whereas the STAS was developed to be used by health care professionals to assess patients, the POS was developed from the outset to have a patient and a staff version. One study using the STAS did involve informal carers; this was an audit of a telephone triage service used by patients, caregivers, and health professionals, which used a modified version of the STAS.
49
Two studies investigated the effect of a palliative care training intervention for health care professionals. 36, 41 The POS was completed by health care professionals and informal caregivers as a retrospective analysis of decedents with dementia, 27 whereas three other similar studies used only caregiver assessments. 13, 15, 44 Four studies incorporated caregiver views on the experience of caring or of palliative care services, and on their views of patients' experiences.
Versions of the POS and STAS
In addition to the original versions of the POS and STAS, several different versions and adaptations were used throughout studies. The POS-S has been used alongside the core POS to assess patients with breathlessness, 21 although some studies used the extended versions of the POS-S; POS-S-PP,  18,23 POS-S-MS,   26 and POS-S-renal. 6 The study using POS-S-renal 6 added nine items to the scale to capture additional symptoms in a renal transplant population, whereas a study assessing heart failure and lung cancer patients 21 used the core POS with POS-S, with the addition of two items from POS-S-PP. 
Translations and Country of Data Collection
There have been numerous translations of the STAS and POS ( New studies using the STAS or POS have a broad geographical scope (Table 3) , with the number of studies from Africa rivaling that of Europe. All 
Purpose of Administration of the POS or STAS
All articles were classified according to the study aim (Fig. 2) . These data were combined with those of the previous review to present the overall categories of use for the POS and STAS (Fig. 3) 14,29,34e39,41e43 Seventeen studies reported use of the POS to assess symptom prevalence or palliative care needs. 6,11,12,15,16,18e23,25,29e31,33,38 One article studied the implementation of the POS as an outcome measure, 34 whereas eight compared patient needs and outcomes in different palliative care settings.
13,15,17,19,36,37,39,41 One study compared patients' and professionals' assessments.
29 Professionals' and informal caregivers' views on the POS were reported in one article. 44 In four studies, the POS was used by informal caregivers to assess patients. 13, 14, 29, 41 Five studies used the STAS to evaluate an intervention.
47e49,51,52 Seven (all but one) of the studies assessed the symptom prevalence among a patient population.
45e48,50e52 One audited the implementation of the STAS as an outcome measure. 49 There were no validation studies or studies using the STAS in a new patient group, culture, or translation.
Methods of Data Collection
Most study data were collected in longitudinal studies with data collected at multiple times, Vol. 50 No. 6 December 2015
both for the STAS (n ¼ 5) 47e51 and POS (n ¼ 22).
11,12,17e19,22,26,27,29e31,33e43 Cross-sectional studies also were used; two for the STAS (both of which used data mining methods) 45, 46 and 13 for the POS.
6,13,15,16,20,21,23,25,28,31,32,37,44 One POS study used qualitative methods to determine the content and construct validity of two items in the POS for African palliative care populations. 24 Two studies, which used the measures as part of a project evaluation, were classified as audits; one using the POS 14 and the other using the STAS. 49 
Discussion
Following the initial, considerable contribution made by the POS and STAS to palliative care, as reported in the previous review, 7 use and translation of these tools has steadily increased. This is indicated by a further eight articles using the STAS and 35 articles using the POS that were published since 2010. During this time, the global reach of these outcome measures has broadened, particularly in Africa, where POS use has now been documented in six additional countries. Similarly, in Europe, several new publications using the POS have come from the U.K., Germany, The Netherlands, and Spain. These findings are in line with a study by Harding et al. 55 which found that the POS was among the top five outcome measures used in research as well as clinical care and audit in Europe. Similarly, Higginson et al. 56 reported that across Europe and Africa, the POS was among the most common measures used by researchers and clinicians alike.
Patterns of use appear to have changed since the last review. Although in the previous review most published studies focused on validation of measures and their translations, or use in new cultures, publications since then have focused more on using the POS, and to a lesser degree the STAS, particularly to study symptom prevalence and evaluate interventions. This may indicate that earlier validation work, as captured by publications included in the previous review, has now resulted in these measures being used as validated and reliable tools to capture symptoms and needs. These findings are in line with a survey by Higginson et al., 56 which found that 88% of POS users and 85% of STAS users used these measures to assess patients' symptoms and needs.
Despite this increase in use of the POS and STAS to assess symptom burden, as evidenced by our results, a recent systematic review found that several barriers still exist that might limit the implementation of outcome measures into routine clinical practice.
57
Among these barriers are a lack of time, resources, and training, as well as measure-and patient-specific issues. Therefore, although the results of this study indicate an increase in the use of these measures, more could be done to support clinicians who wish to implement outcome measures, such as the POS (or STAS), in their clinical practice.
Studies investigating the validity of the POS increased evidence for the validity of this measure. Two studies reported the reliability and concurrent validity of the measure, specifically of the core POS and POS-S-MS. 26, 41 The importance of the ''at peace'' item to patients and bereaved relatives is confirmed by two studies, as is the acceptability of the measure. 24, 44 However, one study reported that, among 10 measures of perceived quality of dying and quality of care, the POS had the least correlation with the other measures. 27 It is unclear, however, whether this indicates that the other measures were more or less reliable than the POS. In combination with the POS validation studies included in the previous review, there is a growing body of evidence for the validity of the POS and its acceptability among patients, caregivers, and health professionals. We also were made aware of ongoing work to develop and validate an IPOS, which combines items from the POS, POS-S, and the APCA African POS (Appendix IV). However, no publications were available about the IPOS at the time of this review. Unfortunately, no further validation studies were identified for the STAS.
In general, there appears to be greater popularity for the POS than for the STAS, with more than four times as many publications for the POS being published over the last four years. This continues the trend identified in the previous review, which also identified more publications for the POS than the STAS. 7 In Africa, the extensive use of the POS is likely linked to the endorsement of this measure by the APCA, as well as the availability of several translated versions.
24,38,54,58 The reason for more frequent use of the POS in other parts of the world might be linked to the increasing popularity of PROMs over the years, as the POS is predominantly a patient-completed measure. Particularly in Europe and the U.S., there has been a push for increased use of PROMs in recent years, which may have impacted the choice of measures, both for research and clinical use.
59,60 However, it is important to note that the POS also exists as a staff-completed measure, as well as a carer-completed measure. Although most studies included in this review used the patient version, some only used the carer version, 13, 15 or used several different versions.
12,41
Included studies did not report on comparisons between patient and proxy versions. Having completed patient and proxy ratings available is valuable, as it enables direct comparison of perceived severity of symptoms from patient and proxy perspectives. Future psychometric studies should include testing of interrater reliability, particularly between patient-and staff-completed versions. Data on patient versus proxy ratings support the validity of measures and ensure the whole of the palliative care population can be included.
Interestingly, the STAS appears to be more popular in China and Japan, with 18 STAS publications overall (including six new publications) from these countries, compared to none for the POS. This may be explained by the lack of fully validated translations of the POS in Chinese or Japanese, although it is worth noting that translation and validation of a Japanese POS is underway. It also may be a result of cultural differences and/ or different health care systems in these countries, which may prefer a more paternalistic approach, with health professionals taking the lead. 61 The STAS and POS were both developed and validated originally in patients with advanced cancer. This is still evident from the STAS publications, but the growing use of the POS among other palliative care populations was noted in the previous review, and this has continued to be the case. There are now numerous publications reporting the use of the POS for patients with nononcological conditions; particularly in patients with HIV/AIDS and neurological conditions. This suggests that palliative needs are beginning to be recognized among a variety of populations beyond those with cancer. In addition, new subsets of previously explored patient populations are now being included in studies, suggesting a growing understanding of palliative needs along disease trajectories and spectrums. Although most of these studies focused on the use of the POS in noncancer populations, two studies reported the validation of the POS; one in MS patients 26 and another in dementia patients. 27 Multiple versions of the POS have been used in studies, including the core POS, POS-S-MS, POS-Srenal, POS-S-PP, and APCA African POS. In particular, there has been wide use of the APCA African POS, mostly for patient populations living with HIV/AIDS. In the previous review, one validation study reported a need for the POS to be better adapted to the needs of patients with motor neuron disease, 62 but use of the POS-S-PP with this population of patients in two studies 18 
Strengths and Limitations
This systematic review incorporated an extensive search for relevant publications, including contacting of subscribers to the POS website and scanning of reference lists to complement the literature search. The findings presented build on an established body of evidence for the use of the POS and the STAS as collated by Bausewein et al. 7 Similarities in the findings of these two reviews in terms of POS and STAS use promote the reliability of our findings. In this review, we counted number of studies rather than publications, to account for multiple reporting and increase the accuracy of the reported results.
A limitation of this review is that it did not pick up use of the POS and the STAS that was not reported in the literature. As both tools are available for use in clinical practice, the present review may somewhat underestimate actual use by clinical teams, which may use these measures to assess and monitor patients' symptoms and needs to inform care. 55, 56 Other limitations of this review include the fact that data extraction was mainly performed by one researcher (E. S. C.) and that only published studies were included, although ongoing research that the authors were aware of is outlined in Appendix IV. Finally, several of the authors were involved in the initial development and validation of the STAS and the POS (C. B., I. J. H., F. E. M. M.), which may somewhat bias them toward a more positive assessment of these measures. However, the range of identified publications from teams not associated with the authors supports the findings that these tools are acceptable and useful.
Conclusion
Overall, the present review shows that the POS, and to a lesser extent the STAS, has continued to be used in a variety of settings and countries since the last review was published. POS use has particularly increased in Europe and Africa, with 12 new African translations. In Asia, use of the STAS is more common. Both measures are now more frequently used in studies that assess symptoms and needs, rather than validation studies, which may be an indication that they are now perceived as reliable and valid tools that can be used for these purposes without the need for further validation. Owing to this widespread use, particularly the POS and to a lesser degree the STAS may be used in the future to compare data internationally and/or to compare symptoms and needs in different disease groups, especially diverse palliative care populations with a range of malignant and nonmalignant diagnoses. Chinese version of STAS.
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